- Home
- SNY vs COP Comparison
SNY vs COP Comparison
Compare SNY & COP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- COP
- Stock Information
- Founded
- SNY 1994
- COP 1917
- Country
- SNY France
- COP United States
- Employees
- SNY N/A
- COP N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- COP Integrated oil Companies
- Sector
- SNY Health Care
- COP Energy
- Exchange
- SNY Nasdaq
- COP Nasdaq
- Market Cap
- SNY 144.8B
- COP 125.9B
- IPO Year
- SNY N/A
- COP N/A
- Fundamental
- Price
- SNY $55.82
- COP $102.35
- Analyst Decision
- SNY Buy
- COP Buy
- Analyst Count
- SNY 2
- COP 17
- Target Price
- SNY $62.50
- COP $132.75
- AVG Volume (30 Days)
- SNY 3.0M
- COP 11.6M
- Earning Date
- SNY 04-24-2025
- COP 05-01-2025
- Dividend Yield
- SNY 3.94%
- COP 3.05%
- EPS Growth
- SNY 2.94
- COP N/A
- EPS
- SNY 4.60
- COP 7.81
- Revenue
- SNY $45,849,466,833.00
- COP $56,450,000,000.00
- Revenue This Year
- SNY $6.91
- COP $12.02
- Revenue Next Year
- SNY $6.60
- COP $3.86
- P/E Ratio
- SNY $23.82
- COP $13.11
- Revenue Growth
- SNY 7.73
- COP N/A
- 52 Week Low
- SNY $45.22
- COP $86.81
- 52 Week High
- SNY $60.12
- COP $135.18
- Technical
- Relative Strength Index (RSI)
- SNY 47.61
- COP 59.37
- Support Level
- SNY $53.98
- COP $101.42
- Resistance Level
- SNY $56.93
- COP $104.87
- Average True Range (ATR)
- SNY 0.78
- COP 2.21
- MACD
- SNY -0.56
- COP 0.71
- Stochastic Oscillator
- SNY 31.19
- COP 78.95
Stock Price Comparison Chart: SNY vs COP
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
About COP ConocoPhillips
ConocoPhillips is a US-based independent exploration and production firm. In 2023, it produced 1.2 million barrels per day of oil and natural gas liquids and 3.1 billion cubic feet per day of natural gas, primarily from Alaska and the Lower 48 in the United States and Norway in Europe and several countries in Asia-Pacific and the Middle East. Proven reserves at year-end 2023 were 6.8 billion barrels of oil equivalent.